James Smith
Psychiatry · Raleigh, NCNPI 1376630681
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,136 of the $2,508 with a category attached, or 85.2%. 19 manufacturers reported payments, led by Abiomed at 26.5% of the total. Reporting peaked in 2019 at $1,587 and has fallen 58.2% since, to $664 in 2025.
Across 134 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$664
- Johnson & Johnson$319
- Lundbeck LLC$247
- AbbVie$201
- Sunovion Pharmaceuticals Inc.$198
- Alkermes, Inc.$170
- plus $710 from 13 others
What the payments were for
- Travel & lodging$37115%
- Food & beverage$2,13685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 6 | $664 |
| Johnson & Johnson | 15 | $319 |
| Lundbeck LLC | 17 | $247 |
| AbbVie | 26 | $201 |
| Sunovion Pharmaceuticals Inc. | 15 | $198 |
| Alkermes, Inc. | 9 | $170 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Shire North American Group Inc | 9 | $108 |
| Neurocrine Biosciences, Inc. | 5 | $85 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Avanir Pharmaceuticals, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Tris Pharma Inc | 3 | $51 |
| Neos Therapeutics, LP | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$134
How this compares
$2,508 in reported general payments places this provider in the 80th percentile of 1,108 psychiatry providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Raloxifene Hcl | 11 | $124 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Raleigh
- Robert MilletRaleigh$476K
- Richard WeislerRaleigh$108K
- Ashwin PatkarRaleigh$103K
- Mona GuptaRaleigh$88K
- Kellie TolinRaleigh$31K
- Celso LobaoRaleigh$28K
- Elizabeth CoxRaleigh$24K
- Myleme HarrisonRaleigh$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.